Anastrozole Tablet
Product Images NDC 82804-162

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 82804-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7b4ba0c5 0287 B7a7 E053 2991aa0a575e

Anastrozole 1 mg oral tablets, shown as white, round tablets with imprint 'YL' on one side and '111' on the other. These tablets are from Proficient Rx LP, designed for human prescription use.*

FDA Label Image

Avet Logo (Avet)

FDA Label Image

Chemical Structure For Anastrozole (Image 01)

Chemical structure diagram of Anastrozole, showing its molecular arrangement with aromatic rings and nitrogen-containing groups.*

FDA Label Image

Figure 1 (Image 02)

A survival curve graph showing disease-free survival in months on the x-axis against the proportion alive and disease-free on the y-axis. Two treatment groups are compared: anastrozole (dashed line) and tamoxifen (solid line). The graph includes numbers of patients at risk for each treatment at various month intervals up to 90 months.*

FDA Label Image

Figure 2 (Image 03)

A Kaplan-Meier survival curve illustrating disease-free survival in months for patients treated with Anastrozole compared to Tamoxifen. The Y-axis represents the proportion alive and disease-free, while the X-axis shows months of follow-up up to 90 months. A table below lists the number of patients at risk over time for each treatment group.*

FDA Label Image

Figure 3 (Image 04)

A Kaplan-Meier survival curve graph comparing Anastrozole and Tamoxifen treatments over 120 months. The y-axis shows the proportion event free, and the x-axis shows time to event in months. The chart includes a table indicating the number of patients at risk at various time points for both treatments.*

FDA Label Image

Figure 4 (Image 05)

A Kaplan-Meier survival curve graph comparing the proportion event-free over time (in months) between patients treated with Anastrozole and Tamoxifen. The x-axis represents time to event in months up to 120 months, and the y-axis represents the proportion event-free ranging from 0.50 to 1.00. Below the graph is a table showing the number of patients at risk at various time points for each treatment group.*

FDA Label Image

Figure 5 (Image 06)

A line graph comparing the proportion not progressed over time (months) between two randomized treatments, Anastrozole and Tamoxifen. The x-axis represents time to progression in months, and the y-axis represents the proportion not progressed. The graph shows survival curves for each treatment group, with a table below indicating the number of patients at risk at different time points.*

FDA Label Image

Figure 6 (Image 07)

A Kaplan-Meier survival curve chart showing the proportion of patients not progressing over time in months. The chart compares two treatments, Anastrozole and Tamoxifen, with separate lines representing each treatment's progression-free proportion across up to 40 months. The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing.*

FDA Label Image

82804-162-30 (Image 08)

Label for Anastrozole 1 mg tablets, 30 count, labeled by Proficient Rx LP. Tablets are described as white, circular, biconvex, with debossed 'YL' on one side and '111' on the other. Manufactured by Beijing Yiling Bio-engineering Technology Co., Ltd., China. Storage instructions note 20°-25°C (68°-77°F). Contains NDC 82804-162-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.